Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). (Q48027252)
Jump to navigation
Jump to search
scientific article published in December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). |
scientific article published in December 2016 |
Statements
1 reference
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). (English)
1 reference
1 reference
Marek Sanak
1 reference
Joanna Chorostowska-Wynimko
1 reference
Riitta Mäkitaro
1 reference
Noel G McElvaney
1 reference
Jonathan Burdon
1 reference
Mark Holmes
1 reference
Allan Glanville
1 reference
Peter A B Wark
1 reference
Philip J Thompson
1 reference
Paul Hernandez
1 reference
Jan Chlumsky
1 reference
Helmut Teschler
1 reference
Niels Seersholm
1 reference
Alan Altraja
1 reference
Paul I Stoicescu
1 reference
Eeva Piitulainen
1 reference
Oliver Vit
1 reference
Marion Wencker
1 reference
Michael A Tortorici
1 reference
Michael Fries
1 reference
Jonathan M Edelman
1 reference
Kenneth R Chapman
1 reference
RAPID Extension Trial Group
1 reference
1 December 2016
1 reference
5
1 reference
51-60
1 reference
1
1 reference
Identifiers
1 reference
1 reference